
  
    
      
        Background_NNP
        
          Clinical_NNP Importance_NNP of_IN a_DT Precancer_NNP
          Classification_NNP
          The_DT best_JJS medical_JJ discoveries_NNS are_VBP generalizable_JJ ._. For_IN
          example_NN ,_, if_IN antibiotics_NNS were_VBD only_RB effective_JJ on_IN a_DT single_JJ
          bacteria_NNS ,_, Alexander_NNP Fleming_NNP 's_POS chance_NN discovery_NN would_MD have_VB
          had_VBN limited_JJ medical_JJ value_NN ._. Bacteria_NNP have_VBP common_JJ
          biological_JJ properties_NNS (_( e_SYM ._. g_SYM ._. a_DT cell_NN wall_NN ,_, small_JJ size_NN ,_,
          etc_FW ._. )_) that_WDT make_VBP them_PRP different_JJ from_IN flowers_NNS ,_, insects_NNS and_CC
          people_NNS ._. Knowledge_NNP of_IN the_DT general_JJ properties_NNS of_IN bacteria_NNS
          can_MD inspire_VB therapeutic_JJ strategies_NNS that_WDT extend_VBP its_PRP$ value_NN
          to_TO all_DT the_DT members_NNS of_IN its_PRP$ class_NN ._. Bacteriologists_NNP learn_VB
          the_DT names_NNS of_IN all_PDT the_DT different_JJ bacteria_NNS and_CC group_VB the_DT
          different_JJ bacteria_NNS based_VBN on_IN shared_VBN properties_NNS ._.
          Bacteriologists_NNP use_NN their_PRP$ knowledge_NN of_IN bacterial_JJ classes_NNS
          to_TO develop_VB new_JJ antibiotics_NNS and_CC new_JJ therapeutic_JJ
          strategies_NNS ._.
          Classification_NNP efforts_NNS typically_RB begin_VBP by_IN listing_VBG all_PDT
          the_DT members_NNS of_IN the_DT classification_NN domain_NN (_( i_NNP ._. e_SYM ._. creating_VBG a_DT
          taxonomy_NN )_) ._. Until_IN now_RB ,_, there_EX has_VBZ been_VBN no_DT effort_NN to_TO list_VB
          the_DT precancers_NNS and_CC or_CC to_TO associate_JJ precancer_NN terms_NNS with_IN
          their_PRP$ synonyms_NNS ._. Any_DT given_VBN precancer_NN may_MD have_VB been_VBN studied_VBN
          by_IN different_JJ researchers_NNS using_VBG different_JJ terms_NNS for_IN the_DT
          same_JJ lesion_NN ._. Absent_VB a_DT definitive_JJ terminology_NN ,_, distinct_JJ
          lesions_NNS may_MD have_VB been_VBN studied_VBN under_IN the_DT same_JJ name_NN ._. The_DT
          absence_NN of_IN a_DT comprehensive_JJ precancer_NN terminology_NN severely_RB
          limits_VBZ the_DT clinical_JJ value_NN of_IN research_NN that_WDT includes_VBZ
          precancer_NN specimens_NNS ._.
          Until_IN now_RB ,_, there_EX has_VBZ been_VBN no_DT effort_NN to_TO group_VB the_DT
          precancers_NNS by_IN shared_VBN clinical_JJ ,_, morphologic_JJ or_CC
          biomolecular_NN features_NNS ._. If_IN an_DT agent_NN were_VBD discovered_VBN that_WDT
          induced_VBD regression_NN of_IN a_DT particular_JJ precancer_NN ,_, there_EX would_MD
          be_VB no_DT organized_VBN precancer_NN classification_NN prompting_VBG anyone_NN
          to_TO select_VB biologically_RB related_VBN lesions_NNS likely_JJ to_TO respond_VB
          to_TO the_DT same_JJ agent_NN ._.
          It_PRP is_VBZ the_DT opinion_NN of_IN the_DT authors_NNS that_IN precancers_NNS
          should_MD have_VB a_DT biological_JJ classification_NN ._. Database_NNP
          annotations_NNS using_VBG the_DT precancer_NN classification_NN will_MD
          provide_VB a_DT mechanism_NN whereby_WRB each_DT precancer_NN ,_, its_PRP$ '_POS related_VBN
          precancerous_JJ lesions_NNS ,_, and_CC the_DT cancers_NNS known_VBN to_TO develop_VB
          from_IN these_DT lesions_NNS ,_, can_MD be_VB linked_VBN with_IN relevant_JJ data_NNS
          contained_VBD in_IN biological_JJ data_NNS sets_NNS (_( e_SYM ._. g_SYM ._. gene_NN expression_NN
          arrays_NNS and_CC proteomics_NNS arrays_NNS ,_, tissue_NN microarrays_NNS ,_,
          pathology_NN data_NNS sets_NNS )_) ._.
        
        
          Informatics_NNP Aspects_NNP of_IN Classification_NNP
          Modern_NNP classifications_NNS serve_VBP as_IN informatics_NNS devices_NNS
          capable_JJ of_IN linking_VBG ,_, integrating_VBG and_CC retrieving_VBG
          information_NN contained_VBD in_IN diverse_JJ biological_JJ data_NNS sets_NNS ._.
          Creators_NNS of_IN biomedical_JJ databases_NNS use_VBP terminologies_NNS to_TO
          annotate_NN individual_JJ data_NNS elements_NNS ._. Data_NNP annotation_NN
          involves_VBZ appending_VBG descriptive_JJ information_NN to_TO
          experimental_JJ data_NNS with_IN the_DT intention_NN of_IN creating_VBG an_DT
          encapsulated_JJ data_NN object_VBP that_WDT can_MD be_VB intelligently_RB
          connected_VBN to_TO related_VBN data_NNS in_IN other_JJ databases_NNS ._. Annotations_NNP
          are_VBP a_DT critical_JJ part_NN of_IN the_DT data_NNS ,_, because_IN the_DT annotations_NNS
          assist_VBP in_IN the_DT discovery_NN of_IN the_DT biological_JJ relevance_NN of_IN
          the_DT data_NNS element_NN ._. Lesions_NNP annotated_JJ with_IN terminology_NN from_IN
          the_DT same_JJ classification_NN can_MD be_VB linked_VBN ,_, even_RB when_WRB they_PRP
          occur_VBP in_IN heterogeneous_JJ data_NNS sets_NNS ._.
          In_IN the_DT last_JJ several_JJ years_NNS ,_, a_DT new_JJ type_NN of_IN data_NNS
          annotation_NN model_NN has_VBZ emerged_VBN that_WDT will_MD greatly_RB enhance_VB
          the_DT research_NN value_NN of_IN publicly_RB available_JJ datasets_NNS ._. This_DT
          model_NN is_VBZ the_DT self-describing_JJ data_NN collection_NN ._. In_IN this_DT
          model_NN ,_, all_DT of_IN the_DT data_NNS fields_NNS are_VBP tagged_VBN by_IN metadata_NN ._.
          Metadata_NNP is_VBZ data_NNS that_WDT describes_VBZ the_DT data_NNS elements_NNS ._. XML_NNP
          (_( Extensible_NNP Mark-up_NNP Language_NNP )_) is_VBZ the_DT most_RBS popular_JJ format_NN
          for_IN metadata_NN annotation_NN [_NN 4_CD ]_NN ._. The_DT precancer_NN
          classification_NN is_VBZ embodied_VBN in_IN an_DT XML_NNP file_NN ._. The_DT data_NNS
          elements_NNS of_IN the_DT classification_NN are_VBP instances_NNS of_IN the_DT
          precancer_NN domain_NN and_CC the_DT properties_NNS of_IN the_DT domain_NN
          instances_NNS ._. Examples_NNS of_IN precancer_NN data_NNS elements_NNS are_VBP values_NNS
          such_JJ as_IN "_'' DCIS_NNP "_'' and_CC "_'' Actinic_NNP keratosis_NNS "_'' and_CC "_'' 000932_CD "_'' and_CC
          "_'' ENG_NNP "_'' ._. The_DT metadata_NN are_VBP the_DT flanking_VBG tags_NNS such_JJ as_IN
          <_NN concept_NN >_NN ,_, <_NN synonym_NN >_NN ,_, <_NN cui_NN >_NN ,_, and_CC
          <_NN language_NN >_NN ._. The_DT Precancer_NNP XML_NNP file_VB itself_PRP is_VBZ
          annotated_JJ with_IN sufficient_JJ information_NN that_DT anyone_NN opening_VBG
          the_DT file_NN can_MD fully_RB understand_VB the_DT file_NN contents_NNS ._.
          Now_RB and_CC in_IN the_DT future_NN ,_, researchers_NNS will_MD need_VB to_TO
          organize_VB their_PRP$ data_NNS in_IN a_DT way_NN that_WDT permits_VBZ thoughtful_JJ
          analysis_NN ._. Laboratories_NNPS will_MD be_VB producing_VBG terabytes_NNS of_IN
          data_NNS ,_, in_IN the_DT form_NN of_IN images_NNS ,_, tissue_NN micoarrays_NNS ,_, gene_NN
          expression_NN arrays_NNS and_CC proteomic_JJ arrays_NNS ._. None_NN of_IN this_DT data_NNS
          will_MD have_VB any_DT value_NN unless_IN it_PRP is_VBZ described_VBN in_IN a_DT standard_JJ
          manner_NN that_IN computers_NNS can_MD understand_VB ._. Classifications_NNP
          exist_VBP to_TO organize_VB the_DT instances_NNS of_IN a_DT domain_NN so_IN that_DT
          information_NN assembled_VBN from_IN databases_NNS can_MD be_VB generalized_JJ
          or_CC related_VBN to_TO defined_VBN taxonomic_JJ groups_NNS ._.
        
        
          Definition_NNP of_IN Precancer_NNP and_CC Common_NNP Terms_NNS in_IN
          Use_NN
          During_IN carcinogenesis_NNS ,_, morphologically_RB identifiable_JJ
          lesions_NNS occur_VBP that_WDT precede_VB the_DT development_NN of_IN invasive_JJ
          cancer_NN ._. These_DT lesions_NNS are_VBP called_VBN precancers_NNS ,_,
          premalignancies_NNS ,_, preneoplastic_JJ lesions_NNS ,_, incipient_NN
          cancers_NNS ,_, intraepithelial_NN neoplasias_NNS ,_, and_CC preinvasive_JJ
          cancers_NNS ._. The_DT plethora_NN of_IN terms_NNS reflects_VBZ the_DT difficulty_NN of_IN
          choosing_VBG a_DT "_'' best_JJS "_'' canonical_JJ class_NN term_NN for_IN the_DT
          precancerous_JJ lesions_NNS ._. Currently_RB ,_, the_DT term_NN
          "_'' intraepithelial_NN neoplasia_NN "_'' seems_VBZ to_TO enjoy_VB wide_JJ usage_NN
          among_IN the_DT community_NN of_IN pathologists_NNS ,_, but_CC this_DT term_NN has_VBZ
          limitations_NNS :_:
          1_LS ._. Not_RB all_DT epithelial_NN precancers_NNS are_VBP intraepithelial_NN ._.
          Most_JJS of_IN the_DT mucosal_NN dysplasias_NNS have_VBP a_DT well-defined_JJ
          territory_NN bounded_JJ by_IN the_DT junction_NN between_IN the_DT epithelium_NN
          and_CC the_DT underlying_VBG stroma_NN ._. But_CC not_RB all_DT premalignant_NN
          epithelial_NN lesions_NNS can_MD be_VB identified_VBN by_IN the_DT presence_NN of_IN
          atypical_JJ cell_NN populations_NNS delimited_JJ by_IN a_DT basement_NN
          membrane_NN ._. Dysplastic_NNP lesions_NNS of_IN the_DT liver_NN ,_, kidney_NN ,_,
          thyroid_NN and_CC adrenal_NN are_VBP not_RB delimited_JJ by_IN a_DT basement_NN
          membrane_NN [_NN 1_CD ]_NN ._.
          2_LS ._. Not_RB all_DT precancers_NNS are_VBP epithelial_NN [_NN 1_CD ]_NN ._.
          Intratubular_NNP germ_NN cell_NN neoplasms_NNS of_IN testis_NNS ,_,
          myelodysplasias_NNS ,_, and_CC non-autonomous_JJ lymphomas_NNS are_VBP
          examples_NNS of_IN non-epithelial_JJ precancers_NNS ._.
          3_LS ._. Not_RB all_DT intraepithelial_NN neoplasms_NNS are_VBP precancers_NNS ._.
          Neoplasms_NNP that_WDT are_VBP intraepithelial_NN but_CC that_WDT are_VBP not_RB
          precancers_NNS include_VB :_: seborrheic_JJ keratoses_NNS ,_, intraepidermal_NN
          nevi_NN ,_, common_JJ warts_NNS and_CC most_RBS so-called_JJ benign_JJ epithelial_NN
          tumors_NNS ._.
          Likewise_RB ,_, the_DT term_NN pre-invasive_JJ cancer_NN raises_VBZ an_DT
          existential_NN question_NN ._. Use_NN of_IN the_DT term_NN "_'' pre-invasive_JJ
          cancer_NN "_'' implies_VBZ that_IN precancers_NNS have_VBP attained_VBN the_DT
          biological_JJ properties_NNS of_IN a_DT cancer_NN ._. This_DT assumption_NN may_MD
          not_RB be_VB true_JJ ._. Precancers_NNP may_MD lack_NN constitutive_JJ properties_NNS
          of_IN cancer_NN or_CC may_MD have_VB certain_JJ attributes_NNS that_WDT are_VBP absent_JJ
          in_IN cancers_NNS ._. At_IN this_DT point_NN ,_, there_EX is_VBZ insufficient_JJ
          knowledge_NN to_TO conclude_VB that_IN precancers_NNS are_VBP types_NNS of_IN
          cancer_NN ._. In_IN this_DT article_NN ,_, the_DT authors_NNS use_VBP the_DT term_NN
          precancers_NNS because_IN this_DT term_NN conveys_VBZ only_RB the_DT defining_VBG
          features_NNS :_: occurrence_NN prior_RB to_TO cancers_NNS ,_, and_CC existence_NN as_IN
          an_DT identifiable_JJ lesion_NN ._.
          When_WRB considering_VBG all_PDT the_DT possible_JJ classes_NNS of_IN
          precancers_NNS ,_, it_PRP is_VBZ worth_JJ noting_VBG that_DT :_:
          1_LS ._. Not_RB all_DT precancers_NNS are_VBP neoplastic_JJ ._. A_DT diffusely_RB
          hyperplastic_JJ lesion_NN with_IN no_DT known_VBN neoplastic_JJ properties_NNS ,_,
          but_CC with_IN a_DT frequent_JJ association_NN with_IN cancer_NN arising_VBG from_IN
          the_DT hyperplastic_JJ tissue_NN ,_, would_MD be_VB considered_VBN a_DT precancer_NN ._.
          Examples_NNS include_VBP diffuse_NN atypical_JJ endometrial_NN
          hyperplasia_NN ,_, AIDS-associated_NNP lymphoid_NN hyperplasia_NN ,_,
          helicobacter-associated_JJ gastric_JJ MALT_NNP hyperplasia_NN ,_, diffuse_NN
          gastric_JJ intestinal_NN metaplasia_NN ,_, etc_FW ._.
          2_LS ._. Precancers_NNP need_VBP not_RB progress_VB to_TO cancer_NN and_CC often_RB
          have_VBP a_DT high_JJ rate_NN of_IN regression_NN [_NN 5_CD 6_CD ]_NN ._. The_DT low-risk_JJ of_IN
          progression_NN to_TO cancer_NN suggests_VBZ a_DT strategy_NN for_IN treatment_NN
          based_VBN on_IN enhancing_VBG the_DT intrinsic_JJ regression_NN rate_NN of_IN
          precancers_NNS [_NN 6_CD ]_NN ._. However_RB ,_, when_WRB a_DT precancer_NN progresses_VBZ ,_,
          cancer_NN is_VBZ the_DT obligate_NN outcome_NN (_( i_NNP ._. e_SYM ._. precancers_NNS never_RB
          progress_NN into_IN types_NNS of_IN lesions_NNS other_JJ than_IN cancer_NN )_) ._. This_DT
          biological_JJ property_NN allows_VBZ us_PRP to_TO infer_NN that_IN agents_NNS that_WDT
          induce_VB precancers_NNS are_VBP carcinogens_NNS ._.
          3_LS ._. The_DT different_JJ kinds_NNS of_IN precancers_NNS may_MD vary_VB in_IN every_DT
          biologic_JJ feature_NN except_IN those_DT specified_VBN in_IN their_PRP$
          definition_NN (_( identifiable_JJ lesions_NNS that_WDT precede_VB the_DT
          development_NN of_IN cancer_NN )_) ._. Since_IN precancers_NNS ,_, by_IN definition_NN ,_,
          are_VBP the_DT morphologic_JJ lesions_NNS that_WDT precede_VB cancers_NNS ,_, one_PRP can_MD
          expect_VB precancers_NNS to_TO occur_VB in_IN a_DT somewhat_RB younger_JJR
          population_NN than_IN the_DT population_NN of_IN people_NNS who_WP have_VBP
          cancers_NNS ._. Using_VBG the_DT same_JJ line_NN of_IN reasoning_NN ,_, one_PRP can_MD expect_VB
          agents_NNS (_( chemical_NN or_CC biological_JJ )_) that_WDT induce_VB precancers_NNS to_TO
          also_RB induce_VB cancers_NNS ._.
        
        
          The_DT biological_JJ diversity_NN of_IN precancers_NNS
          When_WRB the_DT different_JJ precancers_NNS are_VBP listed_VBN ,_, it_PRP becomes_VBZ
          apparent_JJ that_IN they_PRP fall_VBP into_IN very_RB different_JJ biological_JJ
          classes_NNS ._. Consider_VB the_DT following_VBG three_CD lesions_NNS ,_, all_DT of_IN
          which_WDT are_VBP usually_RB considered_VBN to_TO be_VB precancers_NNS :_:
          1_LS ._. Squamous_NNP dysplasia_NN of_IN the_DT uterine_NN cervix_NN ._. Squamous_NNP
          dysplasias_NNS are_VBP microscopic_JJ foci_NN of_IN atypical_JJ squamous_JJ
          cells_NNS ._. They_PRP are_VBP not_RB tumors_NNS in_IN the_DT sense_NN that_IN they_PRP do_VBP not_RB
          present_JJ as_IN a_DT growing_VBG mass_NN ._. In_IN the_DT cervix_NN ,_, they_PRP are_VBP almost_RB
          always_RB associated_VBN with_IN a_DT viral_JJ etiology_NN ._.
          2_LS ._. Tubular_NNP adenoma_NN of_IN colon_NN ._. Tubular_NNP adenomas_NNS are_VBP
          benign_JJ tumors_NNS that_WDT can_MD measure_VB several_JJ centimeters_NNS in_IN
          diameter_NN ._. Nuclear_JJ atypia_NN can_MD be_VB minimal_JJ or_CC marked_VBD ._.
          3_LS ._. Barrett_NNP 's_POS esophagus_JJ ._. This_DT is_VBZ a_DT glandular_NN metaplasia_NN
          occurring_VBG in_IN the_DT esophageal_NN mucosa_NN caused_VBN by_IN local_JJ
          chronic_JJ inflammation_NN ._. These_DT lesions_NNS typically_RB show_VBP no_DT
          nuclear_JJ atypia_NN ._. They_PRP are_VBP associated_VBN with_IN an_DT increased_VBN
          risk_NN of_IN adenocarcinoma_NN of_IN the_DT esophagus_JJ ._.
          What_WP do_VBP these_DT lesions_NNS have_VBP in_IN common_NN ?_. They_PRP are_VBP
          identifiable_JJ lesions_NNS that_WDT can_MD precede_VB the_DT development_NN of_IN
          cancer_NN ._. Other_JJ than_IN that_DT ,_, they_PRP would_MD seem_VB to_TO have_VB very_RB few_JJ
          features_NNS in_IN common_NN ._. The_DT diversity_NN of_IN biological_JJ types_NNS of_IN
          precancers_NNS calls_VBZ for_IN the_DT creation_NN of_IN a_DT precancer_NN
          classification_NN ._.
        
        
          Creating_NNP the_DT Precancer_NNP Classification_NNP
          A_DT classification_NN is_VBZ a_DT hierarchy_NN of_IN taxa_NN (_( informative_JJ
          features_NNS that_WDT characterize_VBP an_DT entity_NN and_CC distinguish_VB it_PRP
          from_IN other_JJ entities_NNS )_) and_CC a_DT set_NN of_IN generalizable_JJ features_NNS
          that_WDT apply_VBP to_TO groups_NNS of_IN taxa_NN ._. For_IN instance_NN ,_, if_IN "_'' chair_NN "_'' is_VBZ
          classified_VBN under_IN "_'' furniture_NN ,_, "_'' then_RB we_PRP can_MD expect_VB that_IN all_DT
          of_IN the_DT generalizations_NNS that_IN we_PRP can_MD form_VB on_IN the_DT topic_NN of_IN
          furniture_NN will_MD apply_VB to_TO chairs_NNS ._. This_DT is_VBZ actually_RB a_DT
          remarkable_JJ concept_NN as_IN it_PRP allows_VBZ us_PRP to_TO apply_VB general_JJ
          knowledge_NN to_TO specific_JJ items_NNS ._. Even_RB if_IN I_PRP know_VBP nothing_NN about_IN
          chairs_NNS ,_, knowing_VBG that_IN a_DT chair_NN is_VBZ a_DT type_NN of_IN furniture_NN
          allows_VBZ me_PRP to_TO infer_NN many_JJ things_NNS about_IN chairs_NNS based_VBN on_IN my_PRP$
          general_JJ knowledge_NN of_IN furniture_NN ._. If_IN furniture_NN is_VBZ something_NN
          that_WDT belongs_VBZ in_IN a_DT house_NN ,_, then_RB a_DT chair_NN belongs_VBZ in_IN a_DT
          house_NN ._.
          The_DT task_NN of_IN classification_NN usually_RB begins_VBZ by_IN listing_VBG
          every_DT member_NN of_IN a_DT domain_NN (_( in_IN this_DT case_NN ,_, every_DT precancer_NN )_)
          and_CC then_RB choosing_VBG groups_NNS that_WDT carry_VBP the_DT greatest_JJS number_NN
          of_IN informative_JJ biological_JJ generalizations_NNS to_TO every_DT member_NN
          of_IN the_DT group_NN ._. The_DT list_NN of_IN every_DT member_NN of_IN a_DT domain_NN is_VBZ
          called_VBN a_DT taxonomy_NN ._. A_DT classification_NN is_VBZ a_DT grouped_VBN taxonomy_NN
          [_NN 7_CD ]_NN ._.
          The_DT process_NN of_IN classifying_VBG lesions_NNS is_VBZ different_JJ from_IN
          the_DT process_NN of_IN identifying_VBG lesions_NNS ._. Identification_NNP
          involves_VBZ assigning_VBG a_DT name_NN [_NN from_IN an_DT existing_VBG
          classification_NN ]_NN to_TO a_DT lesion_NN ._. The_DT distinction_NN between_IN
          classification_NN and_CC identification_NN is_VBZ of_IN great_JJ importance_NN ,_,
          because_IN classification_NN schemes_NNS ,_, unlike_IN identification_NN
          schemes_NNS ,_, have_VBP properties_NNS that_WDT can_MD be_VB of_IN immense_JJ
          importance_NN in_IN medical_JJ research_NN [_NN 7_CD ]_NN ._.
          1_LS ._. A_DT classification_NN contains_VBZ every_DT instance_NN in_IN its_PRP$
          domain_NN ,_, and_CC every_DT instance_NN has_VBZ a_DT single_JJ and_CC unique_JJ slot_NN
          in_IN the_DT classification_NN ._. This_DT facilitates_NNS the_DT design_NN of_IN
          experiments_NNS that_WDT include_VBP every_DT instance_NN of_IN related_VBN
          lesions_NNS ._.
          2_LS ._. Good_JJ classifications_NNS contain_VBP classes_NNS carefully_RB
          selected_VBN to_TO have_VB the_DT maximally_RB informative_JJ set_NN of_IN
          generalizable_JJ features_NNS common_JJ to_TO all_DT the_DT class_NN instances_NNS ._.
          Having_VBG a_DT classification_NN allows_VBZ us_PRP to_TO compare_VB two_CD
          different_JJ instances_NNS based_VBN on_IN the_DT inherited_VBN properities_NNS of_IN
          their_PRP$ classes_NNS ._.
          3_LS ._. Classifications_NNP support_NN annotation_NN using_VBG the_DT
          elements_NNS of_IN the_DT classification_NN (_( classes_NNS and_CC instances_NNS )_) as_IN
          keys_NNS ._. Database_NNP annotation_NN can_MD be_VB used_VBN to_TO improve_VB the_DT
          classification_NN system_NN ._.
          Classifications_NNP are_VBP also_RB different_JJ from_IN ontologies_NNS ._.
          Ontologies_NNP create_VB logical_JJ rules_NNS between_IN specified_VBN members_NNS
          of_IN a_DT group_NN [_NN 8_CD ]_NN ._. Ontologies_NNP are_VBP expected_VBN to_TO have_VB
          "_'' competence_NN "_'' ,_, the_DT ability_NN to_TO respond_VB to_TO queries_NNS that_WDT draw_VBP
          from_IN the_DT formal_JJ relationships_NNS among_IN group_NN members_NNS ._. A_DT
          classification_NN approach_NN was_VBD chosen_VBN ,_, because_IN the_DT two_CD
          primary_JJ goals_NNS of_IN this_DT effort_NN were_VBD to_TO create_VB a_DT
          comprehensive_JJ listing_NN of_IN precancer_NN terms_NNS and_CC to_TO provide_VB a_DT
          broad_JJ hierarchy_NN for_IN precancer_NN concepts_NNS ._. Establishing_VBG a_DT
          set_NN of_IN logical_JJ rules_NNS for_IN the_DT precancers_NNS is_VBZ ,_, at_IN this_DT time_NN ,_,
          not_RB feasible_JJ ._.
        
        
          What_WP precancer_NN classification_NN is_VBZ currently_RB
          available_JJ ?_.
          ICD-O_NNP (_( International_NNP Classification_NNP of_IN Diseases_NNP -_:
          Oncology_NNP )_) lists_NNS virtually_RB no_DT precancerous_JJ lesions_NNS [_NN 9_CD ]_NN ._.
          The_DT ICD-O_NNP is_VBZ used_VBN by_IN cancer_NN registrars_NNS to_TO annotate_NN ,_, in_IN a_DT
          uniform_NN way_NN ,_, cases_NNS of_IN treated_VBN malignancies_NNS ._. With_IN a_DT few_JJ
          exceptions_NNS (_( such_JJ as_IN ductal_NN carcinoma_NN in_IN situ_NN of_IN breast_NN )_)
          the_DT cancer_NN registries_NNS do_VBP not_RB collect_VB information_NN on_IN
          precancers_NNS ._. The_DT National_NNP Cancer_NNP Institute_NNP 's_POS Surveillance_NNP ,_,
          Epidemiology_NNP and_CC End_NN Results_NNS (_( SEER_NNP )_) and_CC the_DT Centers_NNPS for_IN
          Disease_NNP Control_NNP and_CC Prevention_NNP use_NN data_NNS collected_VBN by_IN the_DT
          cancer_NN registries_NNS to_TO compile_VB national_JJ statistics_NNS on_IN the_DT
          incidence_NN of_IN cancer_NN ._. The_DT most_RBS comprehensive_JJ summary_NN of_IN
          the_DT clinical_JJ and_CC pathologic_JJ features_NNS of_IN precancers_NNS is_VBZ
          found_VBN in_IN "_'' Pathology_NNP of_IN Incipient_NNP Neoplasia_NNP "_'' ,_, edited_JJ by_IN
          Henson_NNP and_CC Albores-_NNP Saavedra_NNP [_NN 10_CD ]_NN ._. None_NN of_IN these_DT
          sources_NNS provides_VBZ a_DT classification_NN of_IN the_DT precancers_NNS ._.
        
        
          Precancer_NNP Classification_NNP
          
            1_LS ._. Acquired_VBN microscopic_JJ precancers_NNS
            These_DT are_VBP the_DT lesions_NNS that_IN most_JJS people_NNS think_VBP of_IN when_WRB
            they_PRP hear_VBP the_DT term_NN precancer_NN ._. All_DT of_IN the_DT so-called_JJ
            intraepithelial_NN neoplasias_NNS fall_VBP into_IN this_DT category_NN ._.
            Most_JJS examples_NNS of_IN the_DT microscopic_JJ precancers_NNS occur_VBP
            commonly_RB (_( actinic_JJ keratosis_NNS ,_, cervical_JJ dysplasia_NN )_) ._. They_PRP
            tend_VBP to_TO be_VB multifocal_NN ._. They_PRP tend_VBP to_TO be_VB non-inherited_JJ
            lesions_NNS ,_, often_RB with_IN an_DT identifiable_JJ causation_NN (_( e_SYM ._. g_SYM ._.
            sunlight_NN ,_, human_JJ papillomavirus_JJ infection_NN )_) ._. They_PRP seldom_RB
            occur_VBP in_IN children_NNS ._. Exceptions_NNP are_VBP inherited_VBN diseases_NNS
            that_WDT heighten_VB sensitivity_NN to_TO a_DT causal_NN agent_NN ,_, such_JJ as_IN
            the_DT early_JJ appearance_NN of_IN actinic_JJ keratoses_NNS in_IN children_NNS
            with_IN Xeroderma_NNP Pigmentosum_NNP ._. Morphologically_NNP ,_, they_PRP tend_VBP
            to_TO have_VB a_DT high_JJ degree_NN of_IN nuclear_JJ atypia_NN ._. The_DT
            microscopic_JJ epithelial_NN precancers_NNS grow_VBP by_IN a_DT subtle_JJ
            replacement_NN of_IN the_DT normal_JJ mucosa_NN ,_, without_IN producing_VBG a_DT
            mass_NN ,_, despite_IN many_JJ replicative_JJ cycles_NNS of_IN growth_NN ._. They_PRP
            progress_NN to_TO invasive_JJ cancer_NN while_IN still_RB relatively_RB
            small_JJ ._. The_DT term_NN dysplasia_NN is_VBZ often_RB applied_VBN to_TO these_DT
            lesions_NNS ._. Dysplasia_NNP ,_, in_IN the_DT context_NN of_IN precancer_NN ,_, is_VBZ
            somatically_RB inherited_VBN nuclear_JJ atypia_NN ._. Cytologists_NNP use_NN
            the_DT morphologic_JJ features_NNS of_IN dysplasia_NN to_TO identify_VB
            precancer_NN cells_NNS ._. Class_NNP 1_CD precancers_NNS often_RB have_VBP an_DT
            identifiable_JJ non-dysplastic_JJ stage_NN that_WDT precedes_VBZ the_DT
            appearance_NN of_IN nuclear_JJ atypia_NN (_( e_SYM ._. g_SYM ._. squamous_JJ metaplasia_NN
            of_IN bronchus_JJ ,_, Barrett_NNP 's_POS esophagus_JJ without_IN atypia_NN ,_,
            junctional_NN nevus_JJ ,_, intestinal_NN metaplasia_NN of_IN stomach_NN )_)
          
          
            2_LS ._. Acquired_VBN large_JJ lesions_NNS with_IN morphologic_JJ
            atypia_NN
            These_DT lesions_NNS tend_VBP to_TO have_VB a_DT uniform_NN appearance_NN
            throughout_IN most_JJS of_IN their_PRP$ long_JJ existence_NN ,_, even_RB from_IN the_DT
            smallest_JJS size_NN (_( i_NNP ._. e_SYM ._. they_PRP have_VBP a_DT long_JJ ,_, stable_JJ growth_NN
            phase_NN )_) ._. They_PRP tend_VBP not_RB to_TO have_VB precursor_NN lesions_NNS from_IN
            identifiable_JJ microscopic_JJ precancers_NNS (_( e_SYM ._. g_SYM ._. class_NN 2_CD
            lesions_NNS do_VBP not_RB seem_VB to_TO arise_VB from_IN class_NN 1_CD lesions_NNS )_) ._.
            Their_PRP$ chance_NN of_IN becoming_VBG malignant_JJ usually_RB increases_VBZ as_IN
            the_DT size_NN of_IN the_DT lesion_NN increases_NNS ._. When_WRB they_PRP become_VBP
            malignant_JJ ,_, there_EX is_VBZ usually_RB a_DT morphologically_RB apparent_JJ
            focus_NN from_IN within_IN the_DT large_JJ lesion_NN that_WDT has_VBZ crowding_VBG ,_,
            irregular_JJ growth_NN pattern_NN and_CC marked_VBD cellular_JJ atypia_NN
            that_WDT is_VBZ strikingly_RB different_JJ from_IN the_DT surrounding_VBG
            cells_NNS ._. This_DT focus_NN enlarges_NNS ,_, shows_VBZ frank_JJ invasion_NN ,_, and_CC
            is_VBZ the_DT presumed_VBN origin_NN of_IN the_DT cancer_NN that_WDT develops_VBZ from_IN
            the_DT precancer_NN ._. These_DT lesions_NNS tend_VBP not_RB to_TO regress_NNS
            spontaneously_RB ._. They_PRP tend_VBP to_TO be_VB long-lived_JJ and_CC do_VBP not_RB
            progress_VB to_TO cancer_NN without_IN first_JJ growing_VBG to_TO a_DT large_JJ
            size_NN ._. These_DT lesions_NNS are_VBP often_RB multiple_JJ but_CC do_VBP not_RB occur_VB
            in_IN large_JJ numbers_NNS (_( hundreds_NNS )_) unless_IN there_EX is_VBZ a_DT germline_NN
            mutation_NN ._. Prototypical_NNP acquired_VBD large_JJ precancers_NNS are_VBP
            colon_NN adenoma_NN and_CC myelodysplasia_NN
          
          
            3_LS ._. Precursor_NNP lesions_NNS occurring_VBG with_IN inherited_VBN
            hyperplastic_JJ syndromes_NNS that_WDT often_RB progress_NN to_TO
            cancer_NN
            These_DT lesions_NNS tend_VBP to_TO occur_VB very_RB rarely_RB in_IN the_DT
            general_JJ population_NN ,_, but_CC may_MD occur_VB with_IN a_DT high_JJ
            probability_NN (_( sometimes_RB 100_CD %_NN )_) in_IN patients_NNS carrying_VBG the_DT
            germline_NN mutation_NN ._. The_DT prototypical_JJ lesions_NNS are_VBP the_DT
            Ret-gene_NNP disorders_NNS ._. Mutations_NNP in_IN the_DT RET_NNP gene_NN are_VBP
            associated_VBN with_IN the_DT disorders_NNS multiple_JJ endocrine_NN
            neoplasia_NN ,_, type_NN IIA_NNP (_( MEN_NNP 2_CD A_DT )_) ,_, multiple_JJ endocrine_NN
            neoplasia_NN ,_, type_NN IIB_NNP (_( MEN_NNP 2_CD B_NNP )_) ,_, and_CC hereditary_JJ medullary_JJ
            thyroid_NN carcinoma_NN ._.
            Lesions_NNP in_IN this_DT general_JJ category_NN tend_VBP to_TO have_VB a_DT
            single_JJ gene_NN mutation_NN that_WDT may_MD be_VB the_DT only_JJ lesion_NN found_VBD
            in_IN the_DT precursor_NN lesions_NNS ._. The_DT precuror_NN lesions_NNS tend_VBP to_TO
            have_VB the_DT morphology_NN of_IN simple_JJ hyperplasias_NNS ,_, without_IN
            much_JJ nuclear_JJ atypia_NN ._. Precursor_NNP lesions_NNS tend_VBP to_TO be_VB
            multiple_JJ ,_, sometimes_RB occurring_VBG in_IN the_DT hundreds_NNS ,_, and_CC
            bilateral_JJ in_IN paired_VBN organs_NNS ._. These_DT lesions_NNS tend_VBP to_TO occur_VB
            in_IN a_DT much_RB younger_JJR population_NN than_IN the_DT acquired_VBN
            precancers_NNS ._. The_DT resulting_VBG cancers_NNS can_MD also_RB occur_VB at_IN a_DT
            relatively_RB young_JJ age_NN ._.
          
          
            4_LS ._. Acquired_VBN diffuse_NN hyperplasias_NNS and_CC diffuse_NN
            metaplasias_NNS
            With_IN few_JJ exceptions_NNS ,_, acquired_VBD small_JJ focal_JJ
            metaplasias_NNS and_CC hyperplasias_NNS have_VBP a_DT very_RB low_JJ chance_NN of_IN
            progression_NN to_TO cancer_NN ,_, and_CC have_VBP been_VBN excluded_VBN from_IN the_DT
            classification_NN schema_NN because_IN they_PRP rarely_RB result_VBP in_IN
            cancer_NN without_IN first_JJ growing_VBG into_IN diffuse_NN lesions_NNS (_( the_DT
            class_NN 4_CD lesions_NNS )_) or_CC acquiring_VBG nuclear_JJ atypia_NN (_( class_NN 1_CD
            lesions_NNS )_) ._.
            Diffuse_NNP metaplastic_JJ lesions_NNS commonly_RB precede_VB
            cancers_NNS ._. It_PRP is_VBZ presumed_VBN that_IN all_DT bronchogenic_JJ squamous_JJ
            dysplasia_NN arises_VBZ from_IN squamous_JJ metaplasia_NN ._. The_DT normal_JJ
            bronchus_JJ simply_RB does_VBZ not_RB have_VB any_DT squamous_JJ cells_NNS ._. The_DT
            squamous_JJ cells_NNS in_IN bronchial_NN squamous_JJ dysplasia_NN must_MD
            have_VB originated_VBN from_IN a_DT metaplastic_JJ focus_NN for_IN directly_RB
            from_IN non-squamous_JJ bronchial_NN cells_NNS that_IN differentiated_JJ
            directly_RB to_TO a_DT dysplastic_JJ squamous_JJ phenotype_NN ._.
            The_DT prototypical_JJ lesions_NNS are_VBP the_DT diffuse_NN Barrett_NNP 's_POS
            esophagus_JJ ,_, diffuse_NN intestinal_NN metaplasia_NN of_IN stomach_NN ,_,
            and_CC diffuse_NN endometrial_NN hyperplasia_NN ._. These_DT lesions_NNS tend_VBP
            to_TO have_VB chronic_JJ identifiable_JJ causes_NNS (_( e_SYM ._. g_SYM ._.
            gastroesophageal_NN reflux_NN disease_NN ,_, post_NN lye_NN ingestion_NN
            esophagus_JJ ,_, chronic_JJ gastritis_NNS ,_, long-term_JJ tamoxifen_NN
            therapy_NN )_) ,_, and_CC tend_VBP not_RB to_TO regress_NNS so_RB long_VBP as_IN the_DT
            causation_NN persists_VBZ ._. Small_JJ foci_NN of_IN dysplastic_JJ precancers_NNS
            (_( Class_NNP 1_LS )_) may_MD arise_VB from_IN the_DT diffuse_NN hyperplasias_NNS and_CC
            metaplasias_NNS ._.
            This_DT class_NN of_IN precursor_NN may_MD include_VB the_DT so-called_JJ
            regressing_VBG cancers_NNS ,_, such_JJ as_IN helicobacter-associated_JJ
            maltomas_NNS and_CC AIDS-associated_NNP Kaposi_NNP 's_POS sarcoma_NN that_WDT can_MD
            grow_VB as_IN multiple_JJ tumors_NNS ,_, all_DT of_IN which_WDT can_MD quickly_RB
            regress_NNS when_WRB the_DT causative_JJ agent_NN is_VBZ withdrawn_VBN (_( e_SYM ._. g_SYM ._.
            after_IN antibiotic_JJ treatment_NN for_IN Helicobacter_NNP or_CC after_IN
            normal_JJ immune_JJ status_NN is_VBZ restored_VBN after_IN withdrawal_NN of_IN
            cyclosporine_NN in_IN transplant_NN recipients_NNS )_) ._. This_DT class_NN may_MD
            also_RB include_VB secondary_JJ aplastic_JJ anemia_NN (_( e_SYM ._. g_SYM ._. benzene_NN
            toxicity_NN )_) ,_, where_WRB the_DT marrow_NN is_VBZ repopulated_JJ by_IN an_DT
            emerging_VBG population_NN of_IN hyperplastic_JJ cells_NNS that_WDT carry_VBP a_DT
            a_DT heightened_VBN risk_NN of_IN progressing_VBG to_TO acute_JJ leukemia_NN ._.
          
          
            5_LS ._. Currently_RB unclassified_JJ entities_NNS
            Most_JJS precancers_NNS will_MD fall_VB into_IN one_CD of_IN the_DT first_JJ four_CD
            described_VBD classes_NNS ._. However_RB ,_, classifications_NNS may_MD contain_VB
            a_DT subset_NN of_IN cases_NNS that_WDT defy_VBP facile_NN classification_NN ._. For_IN
            example_NN ,_, the_DT platypus_JJ has_VBZ challenged_VBN animal_NN
            classifiers_NNS ._. Aristotle_NNP had_VBD no_DT trouble_NN recognizing_VBG that_IN
            dolphins_NNS were_VBD mammals_NNS ,_, but_CC it_PRP took_VBD the_DT scientific_JJ
            community_NN two_CD millennia_NN to_TO agree_VB ._.
            We_PRP have_VBP created_VBN an_DT "_'' unclassified_JJ "_'' category_NN of_IN
            precancers_NNS for_IN the_DT current_JJ draft_NN classification_NN
          
          
            6_CD ._. Superclass_NNP and_CC modifiers_NNS
            A_DT superclass_NNS is_VBZ created_VBN to_TO contain_VB general_JJ precancer_NN
            terms_NNS (_( e_SYM ._. g_SYM ._. precancer_NN ,_, dysplasia_NN )_)
          
        
      
      
        Methods_NNP
        The_DT National_NNP Library_NNP of_IN Medicine_NNP 's_POS UMLS_NNP (_( Unified_NNP Medical_NNP
        Language_NNP System_NNP )_) is_VBZ a_DT set_NN of_IN tools_NNS that_WDT facilitate_VBP the_DT use_NN
        of_IN medical_JJ terminologies_NNS and_CC the_DT semantic_JJ relationships_NNS
        between_IN terms_NNS and_CC vocabularies_NNS ._. The_DT UMLS_NNP Metathesaurus_NNP is_VBZ
        one_CD of_IN three_CD knowledge_NN sources_NNS within_IN the_DT UMLS_NNP and_CC contains_VBZ
        concepts_NNS and_CC terms_NNS from_IN about_IN 100_CD different_JJ medical_JJ
        vocabularies_NNS ._. The_DT primary_JJ UMLS_NNP metathesaurus_JJ file_NN used_VBN in_IN
        the_DT construction_NN of_IN the_DT precancer_NN terminology_NN is_VBZ MRCON_NNP ._. The_DT
        2003_CD MRCON_NNP file_VB is_VBZ over_IN 150_CD Mbytes_NNP in_IN length_NN and_CC contains_VBZ
        over_IN two_CD million_CD different_JJ terms_NNS belonging_VBG to_TO nearly_RB a_DT
        million_CD different_JJ concepts_NNS ._. MRCON_NNP and_CC the_DT entire_JJ UMLS_NNP
        metathesaurus_JJ are_VBP available_JJ at_IN no_DT cost_NN from_IN the_DT National_NNP
        Libary_NNP of_IN Medicine_NNP at_IN :_:
        http_NN :_: /_NN /_NN www_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN research_NN /_NN umls_NNS /_NN
        An_DT example_NN of_IN some_DT records_NNS from_IN the_DT MRCON_NNP file_NN is_VBZ
        shown_VBN :_:
        C_NNP 0004763_CD |_NN ENG_NNP |_NN P_NN |_NN L_NNP 0004763_CD |_NN VO_NNP |_NN S_NNP 1397347_CD |_NN Barretts_NNP
        Esophagus_NNP |_NN 0_CD |_NN
        C_NNP 0004763_CD |_NN ENG_NNP |_NN P_NN |_NN L_NNP 0004763_CD |_NN VO_NNP |_NN S_NNP 1397348_CD |_NN Esophagus_NNP ,_,
        Barrett_NNP 's_POS |_NN 0_CD |_NN
        C_NNP 0004763_CD |_NN ENG_NNP |_NN P_NN |_NN L_NNP 0004763_CD |_NN VO_NNP |_NN S_NNP 1459012_CD |_NN barrett_NN 's_POS
        esophagus_JJ |_NN 2_CD |_NN
        C_NNP 0004763_CD |_NN ENG_NNP |_NN P_NN |_NN L_NNP 0004763_CD |_NN VO_NNP |_NN S_NNP 1940341_CD |_NN Barretts_NNP
        esophagus_JJ |_NN 0_CD |_NN
        C_NNP 0004763_CD |_NN ENG_NNP |_NN P_NN |_NN L_NNP 0004763_CD |_NN VW_NNP |_NN S_NNP 0038968_CD |_NN Esophagus_NNP ,_,
        Barrett_NNP |_NN 0_CD |_NN
        C_NNP 0004763_CD |_NN ENG_NNP |_NN S_NNP |_NN L_NNP 0292386_CD |_NN PF_NNP |_NN S_NNP 0364034_CD |_NN Columnar-lined_NNP
        esophagus_JJ |_NN 3_CD |_NN
        C_NNP 0004763_CD |_NN ENG_NNP |_NN S_NNP |_NN L_NNP 0292386_CD |_NN VCW_NNP |_NN S_NNP 0369397_CD |_NN ESOPHAGUS_NNP ,_,
        COLUMNAR-LINED_NNP |_NN 0_CD |_NN
        C_NNP 0004763_CD |_NN ENG_NNP |_NN S_NNP |_NN L_NNP 0292386_CD |_NN VO_NNP |_NN S_NNP 0842892_CD |_NN Columnar-lined_NNP
        oesophagus_JJ |_NN 3_CD |_NN
        Notice_NNP that_IN numerous_JJ variant_NN terms_NNS for_IN Barrett_NNP 's_POS
        esophagus_JJ all_DT map_NN to_TO the_DT same_JJ number_NN in_IN the_DT first_JJ column_NN ,_,
        C_NNP 0004763_CD ._. This_DT is_VBZ the_DT UMLS_NNP CUI_NNP (_( Concept_NNP Unique_NNP Identifier_NNP )_)
        for_IN Barrett_NNP 's_POS esophagus_JJ ._.
        The_DT authors_NNS collected_VBD precancer_NN terms_NNS from_IN the_DT UMLS_NNP ._.
        After_IN review_NN of_IN the_DT terms_NNS ,_, the_DT authors_NNS added_VBD supplemental_JJ
        terms_NNS from_IN their_PRP$ own_JJ knowledge_NN ._. Every_DT additional_JJ term_NN added_VBN
        by_IN the_DT authors_NNS matched_VBD a_DT pre-existing_JJ UMLS_NNP concept_NN ._. About_IN
        10_CD %_NN of_IN the_DT precancer_NN synonyms_NNS were_VBD contributed_VBN by_IN the_DT
        authors_NNS ._.
        After_IN the_DT terminology_NN was_VBD assembled_VBN ,_, the_DT authors_NNS created_VBD
        a_DT classification_NN system_NN and_CC assigned_VBN each_DT precancer_NN term_NN to_TO
        one_CD of_IN the_DT precancer_NN classes_NNS ._. The_DT entire_JJ classification_NN was_VBD
        prepared_VBN as_IN a_DT metadata_NN document_NN using_VBG XML_NNP (_( eXtensible_JJ
        Markup_NNP Language_NNP )_) annotation_NN ._.
      
      
        Results_NNS
        The_DT XML_NNP document_NN containing_VBG the_DT precancer_NN classification_NN
        and_CC all_DT accompanying_VBG metadata_NN is_VBZ PRESUM_NNP ._. XML_NNP (_( 425_CD kilobytes_NNS )_)
        [_NN see_VB Additional_JJ file_NN :_: 3_CD ]_NN ._. An_DT example_NN of_IN the_DT metadata_NN
        annotation_NN in_IN the_DT XML_NNP file_NN is_VBZ :_:
        <_NN concept_NN >_NN <_NN cui_NN >_NN 0432487_CD
        <_NN /_NN cui_NN >_NN <_NN precancer_NN __NN class_NN >_NN Acquired_VBN diffuse_NN
        hyperplasias_NNS /_NN metaplasias_NNS
        <_NN /_NN precancer_NN __NN class_NN >_NN <_NN synonym_NN >_NN
        <_NN term_NN >_NN Post-transplant_NNP lymphoproliferative_JJ
        disorder_NN <_NN /_NN term_NN >_NN <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN PTLD_NNP -_: Post-transplant_NNP
        lymphoproliferative_JJ disorder_NN <_NN /_NN term_NN >_NN
        <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN Post-transp_NNP lymphoprolif_NN
        dis_NNS <_NN /_NN term_NN >_NN <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN PTLD-Post-trns_NNP lymphprolif_NN
        dis_NNS <_NN /_NN term_NN >_NN <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN PTLD_NNP <_NN /_NN term_NN >_NN
        <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN PTLPD_NNP <_NN /_NN term_NN >_NN
        <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN PT-LPD_NNP <_NN /_NN term_NN >_NN
        <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN post_NN transplantation_NN
        lymphoproliferative_JJ disorders_NNS <_NN /_NN term_NN >_NN
        <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN post_NN transplantation_NN
        lymphoproliferative_JJ disorder_NN <_NN /_NN term_NN >_NN
        <_NN /_NN synonym_NN >_NN
        <_NN synonym_NN >_NN <_NN term_NN >_NN post_NN transplantation_NN
        lymphoproliferative_JJ disease_NN <_NN /_NN term_NN >_NN <_NN /_NN synonym_NN >_NN
        <_NN /_NN concept_NN >_NN
        In_IN the_DT example_NN ,_, five_CD metadata_NN tags_NNS are_VBP employed_VBN :_:
        <_NN concept_NN >_NN ,_, <_NN cui_NN >_NN ,_, <_NN precancer_NN __NN class_NN >_NN ,_,
        <_NN term_NN >_NN ,_, <_NN synonym_NN >_NN ,_, along_IN with_IN and_CC their_PRP$
        corresponding_JJ closure_NN tags_NNS (_( marked_VBN by_IN a_DT slash_NN character_NN )_) ._.
        Because_IN XML_NNP is_VBZ case-sensitive_JJ ,_, lower-case_JJ letters_NNS were_VBD
        consistently_RB employed_VBN to_TO simplify_VB implementation_NN ._. The_DT
        <_NN concept_NN >_NN tag_NN indicates_VBZ that_IN a_DT new_JJ concept_NN will_MD
        follow_VB ._. Since_IN all_DT of_IN the_DT precancer_NN concepts_NNS derive_VB from_IN or_CC
        correspond_VB to_TO existing_VBG UMLS_NNP concepts_NNS ,_, it_PRP was_VBD convenient_JJ to_TO
        assign_VB each_DT precancer_NN concept_NN with_IN the_DT UMLS_NNP Concept_NNP Unique_NNP
        Identifier_NNP and_CC mark_VB these_DT with_IN a_DT <_NN cui_NN >_NN tag_NN ._. Each_DT
        precancer_NN concept_NN is_VBZ assigned_VBN one_CD of_IN the_DT precancer_NN classes_NNS ._.
        In_IN this_DT case_NN ,_, the_DT term_NN "_'' PTLD_NNP ,_, post-transplant_JJ
        lymphoproliferative_JJ disorder_NN "_'' is_VBZ assigned_VBN to_TO the_DT precancer_NN
        class_NN of_IN "_'' Acquired_VBN diffuse_NN hyperplasias_NNS /_NN metaplasias_NNS ._. "_'' The_DT
        term_NN is_VBZ flanked_JJ by_IN <_NN term_NN >_NN tags_NNS and_CC the_DT class_NN
        designation_NN is_VBZ flanked_JJ by_IN <_NN precancer_NN __NN class_NN >_NN tags_NNS ._.
        Because_IN the_DT term_NN is_VBZ a_DT synonymous_JJ variant_NN ,_, it_PRP is_VBZ nested_JJ in_IN
        <_NN synonym_NN >_NN tags_NNS ._. Term_NNP and_CC synonym_NN tags_NNS are_VBP used_VBN for_IN
        each_DT of_IN the_DT term_NN variants_NNS of_IN the_DT single_JJ concept_NN ._.
        Raw_NNP XML_NNP files_NNS are_VBP made_VBN difficult_JJ to_TO read_VBN by_IN the_DT large_JJ
        quantity_NN of_IN markup_NN (_( XML_NNP tags_NNS )_) that_IN annotate_NN data_NNS elements_NNS ._.
        Typically_RB ,_, XML_NNP files_NNS are_VBP made_VBN readable_JJ with_IN transformation_NN
        scripts_NNS or_CC with_IN embedded_VBN presentation_NN instructions_NNS
        (_( cascading_VBG style_NN sheets_NNS )_) [_NN 11_CD ]_NN ._. A_DT Perl_NNP script_NN (_( PRESUM_NNP ._. PL_NNP )_)
        was_VBD created_VBN to_TO parse_NN the_DT XML_NNP file_NN ,_, counting_VBG the_DT classified_VBN
        lesions_NNS and_CC outputting_VBG a_DT viewable_JJ HTML_NNP file_VB (_( PRESUM_NNP 2_CD ._. HTM_NNP )_)
        and_CC a_DT summary_NN statement_NN as_IN follows_VBZ :_:
        The_DT total_JJ number_NN of_IN precancer_NN terms_NNS =_SYM >_NN 4700_CD
        The_DT total_JJ number_NN of_IN precancer_NN concepts_NNS =_SYM >_NN 568_CD
        (_( a_DT single_NN concept_NN has_VBZ ,_, on_IN average_JJ ,_, 8_CD ._. 3_CD near-synonymous_JJ
        terms_NNS )_)
        Number_NNP of_IN concepts_NNS falling_VBG in_IN the_DT six_CD precancer_NN
        classes_NNS :_:
        Acquired_VBN microscopic_JJ precancers_NNS =_SYM >_NN 262_CD
        Acquired_VBN diffuse_NN hyperplasias_NNS /_NN metaplasias_NNS =_SYM >_NN 37_CD
        Acquired_VBN large_JJ lesions_NNS with_IN cancerous_JJ potential_JJ =_SYM >_NN
        110_CD
        Precancers_NNP in_IN Inherited_NNP hyperplastic_JJ syndromes_NNS =_SYM >_NN
        25_CD
        Precancer_NNP superclass_NNS and_CC associated_VBN modifiers_NNS =_SYM >_NN
        42_CD
        Unclassified_NNP =_SYM >_NN 92_CD
        Number_NNP of_IN Non-_NNP English_NNP terms_NNS
        Russian_JJ =_SYM >_NN 184_CD
        German_JJ =_SYM >_NN 320_CD
        Finnish_JJ =_SYM >_NN 59_CD
        Italian_JJ =_SYM >_NN 63_CD
        Portuguese_NNP =_SYM >_NN 188_CD
        French_JJ =_SYM >_NN 145_CD
        Spanish_JJ =_SYM >_NN 206_CD
        The_DT viewable_JJ html_NN file_NN is_VBZ provided_VBN as_IN a_DT supplemental_JJ
        file_NN [_NN see_VB Additional_JJ file_NN :_: 1_CD ]_NN with_IN this_DT article_NN ._.
        The_DT most_RBS current_JJ versions_NNS of_IN the_DT Precancer_NNP
        Classification_NNP XML_NNP and_CC the_DT transforming_VBG Perl_NNP script_NN are_VBP
        avaliable_JJ from_IN the_DT following_JJ URL_NNP :_:
        http_NN :_: /_NN /_NN 65_CD ._. 222_CD ._. 228_CD ._. 150_CD /_NN jjb_NN /_NN presum_NN ._. tar_NN ._. gz_NN
      
      
        Discussion_NNP
        
          Limitations_NNPS of_IN the_DT Precancer_NNP Classification_NNP
          
            Issues_NNS of_IN inclusion_NN
            The_DT authors_NNS chose_VBD to_TO err_VB on_IN the_DT side_NN of_IN inclusion_NN
            when_WRB developing_VBG the_DT taxonomy_NN ._. If_IN a_DT lesion_NN was_VBD
            considered_VBN a_DT putative_JJ precancer_NN (_( even_RB when_WRB the_DT evidence_NN
            seemed_VBD doubtful_JJ )_) ,_, it_PRP was_VBD added_VBN to_TO the_DT taxonomy_NN ._.
          
          
            Issues_NNS of_IN exclusion_NN
            How_WRB does_VBZ the_DT classification_NN deal_NN with_IN conditions_NNS
            associated_VBN with_IN cancer_NN but_CC for_IN which_WDT no_DT precancerous_JJ
            lesion_NN is_VBZ known_VBN ?_. These_DT conditions_NNS are_VBP often_RB called_VBN
            cancer_NN syndromes_NNS ._. Persons_NNP identified_VBD (_( possibly_RB through_IN
            genetic_JJ testing_NN )_) with_IN a_DT cancer_NN syndrome_NN who_WP have_VBP not_RB
            yet_RB developed_VBN cancers_NNS may_MD be_VB considered_VBN to_TO be_VB in_IN a_DT
            precancerous_JJ stage_NN of_IN their_PRP$ disease_NN ._. In_IN the_DT absence_NN of_IN
            morphologically_RB identifiable_JJ precancerous_JJ lesions_NNS ,_,
            these_DT conditions_NNS were_VBD excluded_VBN from_IN the_DT classification_NN ._.
            Since_IN these_DT syndromes_NNS may_MD have_VB enormous_JJ relevance_NN to_TO
            our_PRP$ understanding_NN of_IN the_DT carcinogenic_JJ process_NN ,_, they_PRP
            were_VBD collected_VBN as_IN a_DT separate_JJ listing_NN ._. When_WRB the_DT
            precancer_NN classification_NN undergoes_NNS community_NN review_NN ,_,
            these_DT syndromes_NNS may_MD be_VB added_VBN as_IN a_DT distinct_JJ class_NN ._. It_PRP is_VBZ
            available_JJ as_IN a_DT supplemental_JJ file_NN with_IN this_DT publication_NN
            [_NN see_VB Additional_JJ file_NN :_: 2_CD ]_NN ._.
          
          
            Issues_NNS of_IN unclassifiability_NN
            Not_RB all_DT precancerous_JJ lesions_NNS fit_VBP into_IN a_DT biological_JJ
            group_NN ._. In_IN most_JJS cases_NNS ,_, the_DT unclassifiable_JJ lesions_NNS are_VBP
            concept_NN "_'' placeholders_NNS "_'' ,_, such_JJ as_IN "_'' atypical_JJ squamous_JJ
            cells_NNS of_IN undetermined_JJ significance_NN ._. "_''
          
          
            Issues_NNS of_IN omission_NN
            Because_IN the_DT classification_NN was_VBD completed_VBN by_IN two_CD
            authors_NNS ,_, it_PRP is_VBZ presumed_VBN that_IN researchers_NNS in_IN the_DT field_NN
            of_IN precancers_NNS will_MD wish_VB to_TO add_VB lesions_NNS to_TO the_DT taxonomy_NN ._.
            This_DT may_MD be_VB particularly_RB important_JJ for_IN veterinary_JJ and_CC
            comparative_JJ pathologists_NNS ,_, as_IN the_DT current_JJ classification_NN
            is_VBZ heavily_RB weighted_JJ toward_IN human_JJ lesions_NNS ._.
          
          
            Issues_NNS of_IN incorrect_JJ classification_NN
            Classifications_NNP are_VBP hypotheses_NNS about_IN the_DT nature_NN of_IN
            their_PRP$ subject_JJ domain_NN ._. A_DT taxonomist_NN needs_VBZ to_TO place_VB every_DT
            known_VBN instance_NN (_( precancer_NN ,_, in_IN this_DT case_NN )_) somewhere_RB in_IN
            the_DT classification_NN ._. Once_RB this_DT is_VBZ done_VBN ,_, the_DT
            classification_NN can_MD be_VB tested_VBN and_CC re-organized_JJ ._.
          
        
      
      
        Conclusions_NNP
        This_DT work_NN represents_VBZ the_DT first_JJ attempt_NN to_TO create_VB a_DT
        comprehensive_JJ listing_NN of_IN the_DT precancers_NNS ,_, the_DT first_JJ attempt_NN
        to_TO classify_VB precancers_NNS by_IN their_PRP$ biological_JJ properties_NNS and_CC
        the_DT first_JJ attempt_NN to_TO create_VB a_DT pathologic_JJ classification_NN of_IN
        the_DT precancers_NNS that_WDT recognizes_VBZ fundamental_JJ biologic_JJ and_CC
        morphologic_JJ distinctions_NNS (_( taxons_NNS )_) among_IN the_DT precancers_NNS ._. A_DT
        draft_NN classification_NN ,_, placed_VBN into_IN the_DT public_JJ domain_NN ,_, is_VBZ a_DT
        first_JJ step_NN toward_IN a_DT clinically_RB useful_JJ classification_NN of_IN the_DT
        precancers_NNS ._. The_DT metadata_NN format_NN (_( XML_NNP )_) provides_VBZ researchers_NNS
        with_IN access_NN to_TO a_DT comprehensive_JJ ,_, organised_JJ listing_NN that_WDT can_MD
        be_VB used_VBN to_TO annotate_NN and_CC link_NN precancer_NN lesions_NNS contained_VBD in_IN
        biomedical_JJ data_NNS sets_NNS ._. Public_NNP comment_VB is_VBZ welcomed_VBN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        Dr_NNP ._. Berman_NNP wrote_VBD the_DT first_JJ drafts_NNS of_IN the_DT paper_NN and_CC the_DT
        classification_NN ._. Dr_NNP ._. Berman_NNP designed_VBD the_DT XML_NNP metadata_NN and_CC
        wrote_VBD the_DT Perl_NNP script_NN that_WDT transforms_VBZ the_DT XML_NNP file_VBP to_TO HTML_NNP ._.
        Dr_NNP ._. Henson_NNP organized_VBD the_DT NIH_NNP workshop_NN that_WDT developed_VBD the_DT
        conceptual_JJ framework_NN for_IN the_DT classification_NN ._. Dr_NNP ._. Henson_NNP
        edited_JJ multiple_JJ drafts_NNS of_IN the_DT article_NN and_CC the_DT
        classification_NN ._.
        Additional_JJ File_NNP 1_CD
        Presum_NNP ._. htm_NN is_VBZ the_DT classification_NN file_NN for_IN the_DT
        precancers_NNS ,_, in_IN viewable_JJ HTML_NNP format_NN ._.
        Click_NNP here_RB for_IN file_NN
        Additional_JJ File_NNP 2_CD
        Omimprec_NNP ._. htm_NN contains_VBZ inherited_VBN conditions_NNS associated_VBN
        with_IN cancer_NN risks_NNS ,_, in_IN HTML_NNP format_NN ._. OMIM_NNP (_( online_NN Mendelian_NNP
        Inheritance_NNP in_IN Man_NN )_) numbers_NNS are_VBP provided_VBN for_IN each_DT
        lesion_NN ._.
        Click_NNP here_RB for_IN file_NN
        Additional_JJ File_NNP 3_CD
        Presum_NNP ._. tar_NN ._. gz_NN is_VBZ a_DT tarballed-gzipped_JJ compressed_VBN file_VB
        containing_VBG presum_NN ._. xml_NN ,_, the_DT XML_NNP data_NN file_NN of_IN the_DT precancer_NN
        classification_NN ,_, and_CC presum_NN ._. pl_NN ,_, a_DT Perl_NNP script_NN that_WDT
        transforms_VBZ the_DT XML_NNP file_NN into_IN a_DT viewable_JJ HTML_NNP file_VB ,_,
        presum_NN 2_CD ._. htm_NN
        Click_NNP here_RB for_IN file_NN
      
    
  
